Total Payments
$903.89
2024 Payments
$128.54
Companies
18
Transactions
50
Medicare Patients
1,611
Medicare Billing
$109,147

Payment Breakdown by Category

Food & Beverage$903.89 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $903.89 50 100.0%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $162.72 9 $0 (2024)
ABBVIE INC. $109.53 5 $0 (2022)
GlaxoSmithKline, LLC. $108.60 7 $0 (2022)
Daiichi Sankyo Inc. $79.49 5 $0 (2022)
AstraZeneca Pharmaceuticals LP $78.06 5 $0 (2023)
SANOFI PASTEUR INC. $61.42 3 $0 (2023)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $47.53 3 $0 (2022)
Boston Scientific Corporation $39.57 1 $0 (2024)
Janssen Pharmaceuticals, Inc $36.17 2 $0 (2022)
IDORSIA PHARMACEUTICALS US INC $33.43 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $128.54 6 Novo Nordisk Inc ($68.58)
2023 $132.48 6 IDORSIA PHARMACEUTICALS US INC ($33.43)
2022 $375.06 21 ABBVIE INC. ($109.53)
2021 $267.81 17 GlaxoSmithKline, LLC. ($80.00)

All Payment Transactions

50 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/12/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $13.86 General
Category: Obesity
11/14/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $21.18 General
Category: Diabetes
09/16/2024 AngioDynamics, Inc. AURYON LASER SYSTEM 100-120 VAC (Device) Food and Beverage In-kind items and services $20.39 General
Category: PAD
09/04/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $16.54 General
Category: Diabetes
05/30/2024 Boston Scientific Corporation Ranger (Device) Food and Beverage In-kind items and services $39.57 General
Category: Ranger_PI
02/15/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $17.00 General
Category: Diabetes
07/20/2023 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $17.48 General
Category: INSOMNIA
05/25/2023 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $31.64 General
Category: Diabetes
05/04/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $23.06 General
Category: Diabetes
03/23/2023 SANOFI PASTEUR INC. FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE HIGH-DOSE Food and Beverage In-kind items and services $24.28 General
Category: Vaccines
03/02/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $20.07 General
Category: Cardiovascular and Metabolism
01/24/2023 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $15.95 General
Category: INSOMNIA
11/03/2022 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $16.48 General
Category: Diabetes
09/13/2022 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $14.30 General
Category: Iron Deficiency Anemia
08/11/2022 Biohaven Pharmaceutical Holding Company Ltd. NURTEC ODT (Drug) Food and Beverage In-kind items and services $15.10 General
Category: PRIMARY CARE
07/08/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.95 General
Category: Gastroenterology
07/07/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $26.22 General
Category: NEUROSCIENCE
06/25/2022 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $13.05 General
Category: Diabetes
06/23/2022 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $15.89 General
Category: Iron Deficiency Anemia
06/03/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $15.97 General
Category: Cardiovascular & Metabolism
05/27/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $26.06 General
Category: NEUROSCIENCE
05/13/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $26.28 General
Category: NEUROSCIENCE
05/11/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $16.29 General
Category: Gastroenterology
04/15/2022 Merck Sharp & Dohme LLC GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE Food and Beverage In-kind items and services $20.53 General
Category: VACCINE
04/08/2022 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $21.17 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 590 689 $80,785 $46,595
2022 12 537 694 $67,295 $37,724
2021 14 484 536 $42,540 $24,827
Total Patients
1,611
Total Services
1,919
Medicare Billing
$109,147
Procedure Codes
38

All Medicare Procedures & Services

38 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 103 143 $24,310 $15,733 64.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 81 81 $16,200 $12,225 75.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 88 123 $15,375 $8,435 54.9%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 41 45 $3,375 $2,442 72.4%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 45 52 $4,940 $2,317 46.9%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 22 22 $3,300 $1,662 50.4%
99441 Telephone medical discussion with physician, 5-10 minutes Office 2023 31 31 $1,550 $1,225 79.0%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 75 82 $8,200 $949.34 11.6%
G0008 Administration of influenza virus vaccine Office 2023 22 22 $1,100 $791.56 72.0%
36415 Insertion of needle into vein for collection of blood sample Office 2023 57 63 $1,260 $529.20 42.0%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2023 11 11 $825.00 $242.55 29.4%
81002 Urinalysis, manual test Office 2023 14 14 $350.00 $44.33 12.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 93 153 $19,125 $12,008 62.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 66 66 $13,200 $10,168 77.0%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 123 186 $17,670 $9,133 51.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 19 20 $3,400 $2,413 71.0%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2022 18 18 $2,700 $1,257 46.6%
0013A Adm sarscov2 100mcg/0.5ml3rd Office 2022 19 19 $1,900 $895.40 47.1%
G0008 Administration of influenza virus vaccine Office 2022 18 18 $900.00 $636.66 70.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 47 48 $4,800 $574.91 12.0%
36415 Insertion of needle into vein for collection of blood sample Office 2022 84 110 $2,200 $325.89 14.8%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2022 11 11 $825.00 $234.07 28.4%
81002 Urinalysis, manual test Office 2022 18 23 $575.00 $78.97 13.7%
91301 Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use Office 2022 21 22 $0.22 $0.22 100.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 73 103 $12,875 $8,655 67.2%

About Dr. John Sammis, D.O

Dr. John Sammis, D.O is a Student in an Organized Health Care Education/Training Program healthcare provider based in Northport, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2016. The National Provider Identifier (NPI) number assigned to this provider is 1366896227.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Sammis, D.O has received a total of $903.89 in payments from pharmaceutical and medical device companies, with $128.54 received in 2024. These payments were reported across 50 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($903.89).

As a Medicare-enrolled provider, Sammis has provided services to 1,611 Medicare beneficiaries, totaling 1,919 services with total Medicare billing of $109,147. Data is available for 3 years (2021–2023), covering 38 distinct procedure/service records.

Practice Information

Products in Payments

  • Rybelsus (Drug) $81.09
  • INJECTAFER (Drug) $79.49
  • UBRELVY (Drug) $78.56
  • TRELEGY ELLIPTA (Drug) $76.60
  • Ozempic (Drug) $67.77
  • FARXIGA (Drug) $47.97
  • XIFAXAN (Drug) $47.53
  • FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $42.50
  • Ranger (Device) $39.57
  • XARELTO (Drug) $36.17
  • QUVIVIQ (Drug) $33.43
  • ANORO ELLIPTA (Drug) $32.00
  • JARDIANCE (Drug) $31.64
  • QULIPTA (Drug) $30.97
  • BREZTRI (Drug) $30.09
  • GARDASIL 9 (Biological) $20.53
  • AURYON LASER SYSTEM 100-120 VAC (Device) $20.39
  • MYRBETRIQ (Drug) $19.21
  • FLUZONE HIGH-DOSE (Biological) $18.92
  • NURTEC ODT (Drug) $15.10

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Northport